CD8A and neoplasm: When 4T1 murine tumors were ~65mm3, three i.t. deliveries, three days apart, of the highest concentration of prodrug led to tumor regression but not elimination, and this cohort had higher anti-tumoral CD8+ T cell levels compared to the vehicle treated group.